{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:38:08Z","timestamp":1795088288514,"version":"4.10.2"},"reference-count":36,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We explored whether the five previously reported molecular subtypes in breast cancer show a preference for organ-specific relapse and searched for molecular pathways involved. The \u201cintrinsic\u201d gene list describing the subtypes was used to classify 344 primary breast tumors of lymph node\u2013negative patients. Fisher exact tests were used to determine the association between a tumor subtype and a particular site of distant relapse in these patients who only received local treatment. Modulated genes and pathways were identified in the various groups using Significance Analysis of Microarrays and Global Testing. Bone relapse patients were most abundant in the luminal subtypes but were found less than expected in the basal subtype. The reverse was true for lung and brain relapse patients with the remark that absence of lung relapse was luminal A specific. Finally, a pleura relapse, although rare, was found almost exclusively in both luminal subtypes. Many differentially expressed genes were identified, of which several were in common in a subtype and the site to which the subtype preferentially relapsed. WNT signaling was up-regulated in the basal subtype and in brain-specific relapse, and down-modulated in the luminal B subtype and in bone-specific relapse. Focal adhesion was found up-regulated in the luminal A subtype but down-regulated in lung relapse. The five major molecular subtypes in breast cancer are evidently different with regard to their ability to metastasize to distant organ(s), and share biological features and pathways with their preferred distant metastatic site. [Cancer Res 2008;68(9):3108\u201314]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-5644","type":"journal-article","created":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T21:11:48Z","timestamp":1209676308000},"page":"3108-3114","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":699,"title":["Subtypes of Breast Cancer Show Preferential Site of Relapse"],"prefix":"10.1158","volume":"68","author":[{"given":"Marcel","family":"Smid","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute;"},{"name":"2Cancer Genomics Centre, Rotterdam, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Wang","sequence":"additional","affiliation":[{"name":"3Veridex LLC, a Johnson & Johnson Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"3Veridex LLC, a Johnson & Johnson Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anieta M.","family":"Sieuwerts","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Yu","sequence":"additional","affiliation":[{"name":"3Veridex LLC, a Johnson & Johnson Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.M.","family":"Klijn","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Foekens","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.M.","family":"Martens","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,5,1]]},"reference":[{"key":"2022061700421265100_B1","doi-asserted-by":"crossref","unstructured":"Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature\u20082000; 406: 747\u201352.","DOI":"10.1038\/35021093"},{"key":"2022061700421265100_B2","doi-asserted-by":"crossref","unstructured":"Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A\u20082001; 98: 10869\u201374.","DOI":"10.1073\/pnas.191367098"},{"key":"2022061700421265100_B3","doi-asserted-by":"crossref","unstructured":"Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A\u20082003; 100: 8418\u201323.","DOI":"10.1073\/pnas.0932692100"},{"key":"2022061700421265100_B4","doi-asserted-by":"crossref","unstructured":"Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res\u20082005; 11: 5678\u201385.","DOI":"10.1158\/1078-0432.CCR-04-2421"},{"key":"2022061700421265100_B5","doi-asserted-by":"crossref","unstructured":"Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol\u20082006; 24: 2261\u20137.","DOI":"10.1200\/JCO.2005.03.8802"},{"key":"2022061700421265100_B6","doi-asserted-by":"crossref","unstructured":"Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell\u20082003; 3: 537\u201349.","DOI":"10.1016\/S1535-6108(03)00132-6"},{"key":"2022061700421265100_B7","doi-asserted-by":"crossref","unstructured":"Deckers M, van Dinther M, Buijs J, et al. The tumor suppressor Smad4 is required for transforming growth factor \u03b2-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res\u20082006; 66: 2202\u20139.","DOI":"10.1158\/0008-5472.CAN-05-3560"},{"key":"2022061700421265100_B8","doi-asserted-by":"crossref","unstructured":"Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature\u20082005; 436: 518\u201324.","DOI":"10.1038\/nature03799"},{"key":"2022061700421265100_B9","doi-asserted-by":"crossref","unstructured":"Norton L, Massague J. Is cancer a disease of self-seeding? Nat Med\u20082006; 12: 875\u20138.","DOI":"10.1038\/nm0806-875"},{"key":"2022061700421265100_B10","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev\u20081989; 8: 98\u2013101."},{"key":"2022061700421265100_B11","doi-asserted-by":"crossref","unstructured":"Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet\u20082005; 365: 671\u20139.","DOI":"10.1016\/S0140-6736(05)17947-1"},{"key":"2022061700421265100_B12","doi-asserted-by":"crossref","unstructured":"Yu JX, Sieuwerts AM, Zhang Y, et al. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer\u20082007; 7: 182.","DOI":"10.1186\/1471-2407-7-182"},{"key":"2022061700421265100_B13","doi-asserted-by":"crossref","unstructured":"Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A\u20081998; 95: 14863\u20138.","DOI":"10.1073\/pnas.95.25.14863"},{"key":"2022061700421265100_B14","doi-asserted-by":"crossref","unstructured":"McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC, Simon R. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics\u20082002; 18: 1462\u20139.","DOI":"10.1093\/bioinformatics\/18.11.1462"},{"key":"2022061700421265100_B15","doi-asserted-by":"crossref","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A\u20082001; 98: 5116\u201321.","DOI":"10.1073\/pnas.091062498"},{"key":"2022061700421265100_B16","doi-asserted-by":"crossref","unstructured":"Goeman JJ, Oosting J, Cleton-Jansen AM, Anninga JK, van Houwelingen HC. Testing association of a pathway with survival using gene expression data. Bioinformatics\u20082005; 21: 1950\u20137.","DOI":"10.1093\/bioinformatics\/bti267"},{"key":"2022061700421265100_B17","doi-asserted-by":"crossref","unstructured":"Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics\u20082004; 20: 93\u20139.","DOI":"10.1093\/bioinformatics\/btg382"},{"key":"2022061700421265100_B18","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res\u20082000; 28: 27\u201330.","DOI":"10.1093\/nar\/28.1.27"},{"key":"2022061700421265100_B19","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat\u20081979; 6: 65\u201370."},{"key":"2022061700421265100_B20","doi-asserted-by":"crossref","unstructured":"Ashburner M, Ball CA, Blake JA, et al. The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat Genet\u20082000; 25: 25\u20139.","DOI":"10.1038\/75556"},{"key":"2022061700421265100_B21","doi-asserted-by":"crossref","unstructured":"Harris MA, Clark J, Ireland A, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res\u20082004; 32: D258\u201361.","DOI":"10.1093\/nar\/gkh036"},{"key":"2022061700421265100_B22","doi-asserted-by":"crossref","unstructured":"Chang HY, Sneddon JB, Alizadeh AA, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol\u20082004; 2: E7.","DOI":"10.1371\/journal.pbio.0020007"},{"key":"2022061700421265100_B23","doi-asserted-by":"crossref","unstructured":"West RB, Nuyten DS, Subramanian S, et al. Determination of stromal signatures in breast carcinoma. PLoS Biol\u20082005; 3: e187.","DOI":"10.1371\/journal.pbio.0030187"},{"key":"2022061700421265100_B24","doi-asserted-by":"crossref","unstructured":"Chi JT, Wang Z, Nuyten DS, et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med\u20082006; 3: e47.","DOI":"10.1371\/journal.pmed.0030047"},{"key":"2022061700421265100_B25","doi-asserted-by":"crossref","unstructured":"Winter SC, Buffa FM, Silva P, et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res\u20082007; 67: 3441\u20139.","DOI":"10.1158\/0008-5472.CAN-06-3322"},{"key":"2022061700421265100_B26","doi-asserted-by":"crossref","unstructured":"Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res\u20082007; 67: 4157\u201363.","DOI":"10.1158\/0008-5472.CAN-06-2355"},{"key":"2022061700421265100_B27","doi-asserted-by":"crossref","unstructured":"Hu Z, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics\u20082006; 7: 96.","DOI":"10.1186\/1471-2164-7-96"},{"key":"2022061700421265100_B28","doi-asserted-by":"crossref","unstructured":"Golan T, Yaniv A, Bafico A, Liu G, Gazit A. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. \u03b2-catenin signaling cascade. J Biol Chem\u20082004; 279: 14879\u201388.","DOI":"10.1074\/jbc.M306421200"},{"key":"2022061700421265100_B29","doi-asserted-by":"crossref","unstructured":"Zirn B, Samans B, Wittmann S, et al. Target genes of the WNT\/\u03b2-catenin pathway in Wilms tumors. Genes Chromosomes Cancer\u20082006; 45: 565\u201374.","DOI":"10.1002\/gcc.20319"},{"key":"2022061700421265100_B30","doi-asserted-by":"crossref","unstructured":"Fogarty MP, Kessler JD, Wechsler-Reya RJ. Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J Neurobiol\u20082005; 64: 458\u201375.","DOI":"10.1002\/neu.20166"},{"key":"2022061700421265100_B31","doi-asserted-by":"crossref","unstructured":"Ferrucci PF, Rabascio C, Mazzetta C, et al. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer. Clin Cancer Res\u20082004; 10: 6039\u201346.","DOI":"10.1158\/1078-0432.CCR-03-0453"},{"key":"2022061700421265100_B32","doi-asserted-by":"crossref","unstructured":"Span PN, Waanders E, Manders P, et al. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J Clin Oncol\u20082004; 22: 691\u20138.","DOI":"10.1200\/JCO.2004.01.072"},{"key":"2022061700421265100_B33","doi-asserted-by":"crossref","unstructured":"Zafrakas M, Petschke B, Donner A, et al. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies. BMC Cancer\u20082006; 6: 88.","DOI":"10.1186\/1471-2407-6-88"},{"key":"2022061700421265100_B34","doi-asserted-by":"crossref","unstructured":"Minn AJ, Gupta GP, Padua D, et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A\u20082007; 104: 6740\u20135.","DOI":"10.1073\/pnas.0701138104"},{"key":"2022061700421265100_B35","doi-asserted-by":"crossref","unstructured":"Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood\u20082006; 107: 1761\u20137.","DOI":"10.1182\/blood-2005-08-3182"},{"key":"2022061700421265100_B36","doi-asserted-by":"crossref","unstructured":"Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature\u20082001; 410: 50\u20136.","DOI":"10.1038\/35065016"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/9\/3108\/2602120\/3108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/9\/3108\/2602120\/3108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:34:30Z","timestamp":1655433270000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/9\/3108\/543151\/Subtypes-of-Breast-Cancer-Show-Preferential-Site"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2008,5,1]]},"published-print":{"date-parts":[[2008,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-5644","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6497768.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497768","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22375316","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22375319","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22375319.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22375316.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22375322.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22375322","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}